nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvastatin—UGT2B7—Mycophenolic acid—systemic scleroderma	0.115	0.147	CbGbCtD
Fluvastatin—UGT1A1—Mycophenolic acid—systemic scleroderma	0.0993	0.127	CbGbCtD
Fluvastatin—SLC15A1—Lisinopril—systemic scleroderma	0.076	0.0971	CbGbCtD
Fluvastatin—SLCO1B3—Mycophenolate mofetil—systemic scleroderma	0.066	0.0842	CbGbCtD
Fluvastatin—UGT2B7—Mycophenolate mofetil—systemic scleroderma	0.0642	0.082	CbGbCtD
Fluvastatin—SLC15A1—Captopril—systemic scleroderma	0.0569	0.0727	CbGbCtD
Fluvastatin—UGT1A1—Mycophenolate mofetil—systemic scleroderma	0.0555	0.0708	CbGbCtD
Fluvastatin—CYP2C8—Mometasone—systemic scleroderma	0.0408	0.0521	CbGbCtD
Fluvastatin—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.0384	0.049	CbGbCtD
Fluvastatin—SLCO1B3—Methotrexate—systemic scleroderma	0.0265	0.0338	CbGbCtD
Fluvastatin—CYP1A2—Pentoxifylline—systemic scleroderma	0.0213	0.0273	CbGbCtD
Fluvastatin—CYP1A2—Leflunomide—systemic scleroderma	0.0204	0.026	CbGbCtD
Fluvastatin—CYP2C9—Leflunomide—systemic scleroderma	0.0184	0.0234	CbGbCtD
Fluvastatin—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0169	0.0216	CbGbCtD
Fluvastatin—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0163	0.0208	CbGbCtD
Fluvastatin—SLCO1B1—Methotrexate—systemic scleroderma	0.0154	0.0197	CbGbCtD
Fluvastatin—CYP2D6—Captopril—systemic scleroderma	0.0132	0.0168	CbGbCtD
Fluvastatin—CYP2C19—Prednisone—systemic scleroderma	0.0109	0.0139	CbGbCtD
Fluvastatin—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00659	0.00842	CbGbCtD
Fluvastatin—CYP2C9—cardial valve—systemic scleroderma	0.0065	0.318	CbGeAlD
Fluvastatin—CYP3A4—Prednisone—systemic scleroderma	0.00527	0.00673	CbGbCtD
Fluvastatin—UGT1A3—digestive system—systemic scleroderma	0.00137	0.067	CbGeAlD
Fluvastatin—HMGCR—connective tissue—systemic scleroderma	0.000806	0.0393	CbGeAlD
Fluvastatin—SLCO1B3—lung—systemic scleroderma	0.000805	0.0393	CbGeAlD
Fluvastatin—UGT2B7—digestive system—systemic scleroderma	0.000788	0.0385	CbGeAlD
Fluvastatin—HMGCR—smooth muscle tissue—systemic scleroderma	0.000737	0.036	CbGeAlD
Fluvastatin—HMGCR—skin of body—systemic scleroderma	0.000727	0.0355	CbGeAlD
Fluvastatin—UGT1A1—digestive system—systemic scleroderma	0.00067	0.0327	CbGeAlD
Fluvastatin—SLC15A1—digestive system—systemic scleroderma	0.000602	0.0294	CbGeAlD
Fluvastatin—HMGCR—digestive system—systemic scleroderma	0.000582	0.0284	CbGeAlD
Fluvastatin—SLCO1B1—digestive system—systemic scleroderma	0.000557	0.0272	CbGeAlD
Fluvastatin—HMGCR—tendon—systemic scleroderma	0.000554	0.027	CbGeAlD
Fluvastatin—SLCO2B1—digestive system—systemic scleroderma	0.000493	0.0241	CbGeAlD
Fluvastatin—HMGCR—lung—systemic scleroderma	0.000486	0.0237	CbGeAlD
Fluvastatin—SLCO2B1—tendon—systemic scleroderma	0.000469	0.0229	CbGeAlD
Fluvastatin—SLCO2B1—lung—systemic scleroderma	0.000412	0.0201	CbGeAlD
Fluvastatin—CYP1A1—skin of body—systemic scleroderma	0.000366	0.0179	CbGeAlD
Fluvastatin—CYP2C19—digestive system—systemic scleroderma	0.000363	0.0177	CbGeAlD
Fluvastatin—CYP2B6—skin of body—systemic scleroderma	0.000355	0.0174	CbGeAlD
Fluvastatin—CYP1A2—digestive system—systemic scleroderma	0.000297	0.0145	CbGeAlD
Fluvastatin—CYP1A1—digestive system—systemic scleroderma	0.000293	0.0143	CbGeAlD
Fluvastatin—CYP3A5—digestive system—systemic scleroderma	0.000286	0.014	CbGeAlD
Fluvastatin—CYP2B6—digestive system—systemic scleroderma	0.000284	0.0139	CbGeAlD
Fluvastatin—CYP2C9—digestive system—systemic scleroderma	0.000282	0.0137	CbGeAlD
Fluvastatin—CYP1A2—lung—systemic scleroderma	0.000248	0.0121	CbGeAlD
Fluvastatin—CYP1A1—lung—systemic scleroderma	0.000244	0.0119	CbGeAlD
Fluvastatin—CYP3A5—lung—systemic scleroderma	0.000239	0.0117	CbGeAlD
Fluvastatin—CYP2B6—lung—systemic scleroderma	0.000237	0.0116	CbGeAlD
Fluvastatin—CYP3A4—digestive system—systemic scleroderma	0.000215	0.0105	CbGeAlD
Fluvastatin—CYP2D6—digestive system—systemic scleroderma	0.000211	0.0103	CbGeAlD
Fluvastatin—Infection—Lisinopril—systemic scleroderma	0.000176	0.000895	CcSEcCtD
Fluvastatin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000175	0.000892	CcSEcCtD
Fluvastatin—Shock—Lisinopril—systemic scleroderma	0.000174	0.000886	CcSEcCtD
Fluvastatin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000884	CcSEcCtD
Fluvastatin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000173	0.000882	CcSEcCtD
Fluvastatin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000173	0.000881	CcSEcCtD
Fluvastatin—Body temperature increased—Azathioprine—systemic scleroderma	0.000172	0.000878	CcSEcCtD
Fluvastatin—Abdominal pain—Azathioprine—systemic scleroderma	0.000172	0.000878	CcSEcCtD
Fluvastatin—Skin disorder—Lisinopril—systemic scleroderma	0.000172	0.000875	CcSEcCtD
Fluvastatin—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000171	0.000872	CcSEcCtD
Fluvastatin—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000171	0.000871	CcSEcCtD
Fluvastatin—Diarrhoea—Captopril—systemic scleroderma	0.000171	0.000871	CcSEcCtD
Fluvastatin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000171	0.00087	CcSEcCtD
Fluvastatin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000171	0.000869	CcSEcCtD
Fluvastatin—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00017	0.000867	CcSEcCtD
Fluvastatin—Erectile dysfunction—Prednisone—systemic scleroderma	0.00017	0.000867	CcSEcCtD
Fluvastatin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00017	0.000866	CcSEcCtD
Fluvastatin—Feeling abnormal—Leflunomide—systemic scleroderma	0.00017	0.000864	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00017	0.000864	CcSEcCtD
Fluvastatin—Fatigue—Mycophenolic acid—systemic scleroderma	0.000169	0.000862	CcSEcCtD
Fluvastatin—Nausea—Mometasone—systemic scleroderma	0.000169	0.00086	CcSEcCtD
Fluvastatin—Anorexia—Lisinopril—systemic scleroderma	0.000169	0.000859	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000168	0.000857	CcSEcCtD
Fluvastatin—Pain—Mycophenolic acid—systemic scleroderma	0.000168	0.000855	CcSEcCtD
Fluvastatin—Constipation—Mycophenolic acid—systemic scleroderma	0.000168	0.000855	CcSEcCtD
Fluvastatin—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000167	0.00085	CcSEcCtD
Fluvastatin—Cough—Mycophenolate mofetil—systemic scleroderma	0.000166	0.000844	CcSEcCtD
Fluvastatin—Dizziness—Captopril—systemic scleroderma	0.000165	0.000841	CcSEcCtD
Fluvastatin—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000164	0.000835	CcSEcCtD
Fluvastatin—Urticaria—Leflunomide—systemic scleroderma	0.000164	0.000833	CcSEcCtD
Fluvastatin—Abdominal pain—Leflunomide—systemic scleroderma	0.000163	0.000829	CcSEcCtD
Fluvastatin—Body temperature increased—Leflunomide—systemic scleroderma	0.000163	0.000829	CcSEcCtD
Fluvastatin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000162	0.000824	CcSEcCtD
Fluvastatin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000162	0.000824	CcSEcCtD
Fluvastatin—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000162	0.000824	CcSEcCtD
Fluvastatin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000162	0.000824	CcSEcCtD
Fluvastatin—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000162	0.000822	CcSEcCtD
Fluvastatin—Breast disorder—Methotrexate—systemic scleroderma	0.000161	0.000822	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000161	0.000821	CcSEcCtD
Fluvastatin—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000161	0.000821	CcSEcCtD
Fluvastatin—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000161	0.000819	CcSEcCtD
Fluvastatin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000161	0.000818	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000161	0.000818	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000161	0.000818	CcSEcCtD
Fluvastatin—Insomnia—Lisinopril—systemic scleroderma	0.00016	0.000815	CcSEcCtD
Fluvastatin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000814	CcSEcCtD
Fluvastatin—Paraesthesia—Lisinopril—systemic scleroderma	0.000159	0.000809	CcSEcCtD
Fluvastatin—Vomiting—Captopril—systemic scleroderma	0.000159	0.000809	CcSEcCtD
Fluvastatin—Dyspnoea—Lisinopril—systemic scleroderma	0.000158	0.000803	CcSEcCtD
Fluvastatin—Rash—Captopril—systemic scleroderma	0.000158	0.000802	CcSEcCtD
Fluvastatin—Dermatitis—Captopril—systemic scleroderma	0.000157	0.000801	CcSEcCtD
Fluvastatin—Headache—Captopril—systemic scleroderma	0.000157	0.000797	CcSEcCtD
Fluvastatin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000156	0.000796	CcSEcCtD
Fluvastatin—Dyspepsia—Lisinopril—systemic scleroderma	0.000156	0.000793	CcSEcCtD
Fluvastatin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000155	0.000791	CcSEcCtD
Fluvastatin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000155	0.000791	CcSEcCtD
Fluvastatin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000789	CcSEcCtD
Fluvastatin—Infection—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000784	CcSEcCtD
Fluvastatin—Decreased appetite—Lisinopril—systemic scleroderma	0.000154	0.000783	CcSEcCtD
Fluvastatin—Eosinophilia—Methotrexate—systemic scleroderma	0.000153	0.000779	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000153	0.000778	CcSEcCtD
Fluvastatin—Fatigue—Lisinopril—systemic scleroderma	0.000153	0.000777	CcSEcCtD
Fluvastatin—Shock—Mycophenolate mofetil—systemic scleroderma	0.000153	0.000777	CcSEcCtD
Fluvastatin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000152	0.000774	CcSEcCtD
Fluvastatin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000152	0.000773	CcSEcCtD
Fluvastatin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000152	0.000773	CcSEcCtD
Fluvastatin—Pancreatitis—Methotrexate—systemic scleroderma	0.000151	0.000771	CcSEcCtD
Fluvastatin—Pain—Lisinopril—systemic scleroderma	0.000151	0.000771	CcSEcCtD
Fluvastatin—Constipation—Lisinopril—systemic scleroderma	0.000151	0.000771	CcSEcCtD
Fluvastatin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000767	CcSEcCtD
Fluvastatin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00015	0.000763	CcSEcCtD
Fluvastatin—Diarrhoea—Azathioprine—systemic scleroderma	0.000149	0.00076	CcSEcCtD
Fluvastatin—Nausea—Captopril—systemic scleroderma	0.000148	0.000756	CcSEcCtD
Fluvastatin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000148	0.000753	CcSEcCtD
Fluvastatin—Asthenia—Leflunomide—systemic scleroderma	0.000148	0.000752	CcSEcCtD
Fluvastatin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000146	0.000743	CcSEcCtD
Fluvastatin—Pruritus—Leflunomide—systemic scleroderma	0.000146	0.000742	CcSEcCtD
Fluvastatin—Connective tissue disorder—Prednisone—systemic scleroderma	0.000145	0.00074	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000145	0.000737	CcSEcCtD
Fluvastatin—Dizziness—Azathioprine—systemic scleroderma	0.000144	0.000734	CcSEcCtD
Fluvastatin—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000144	0.000731	CcSEcCtD
Fluvastatin—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000142	0.000724	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000141	0.000719	CcSEcCtD
Fluvastatin—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000141	0.000718	CcSEcCtD
Fluvastatin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000141	0.000718	CcSEcCtD
Fluvastatin—Diarrhoea—Leflunomide—systemic scleroderma	0.000141	0.000717	CcSEcCtD
Fluvastatin—Urticaria—Lisinopril—systemic scleroderma	0.000141	0.000716	CcSEcCtD
Fluvastatin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00014	0.000714	CcSEcCtD
Fluvastatin—Abdominal pain—Lisinopril—systemic scleroderma	0.00014	0.000712	CcSEcCtD
Fluvastatin—Body temperature increased—Lisinopril—systemic scleroderma	0.00014	0.000712	CcSEcCtD
Fluvastatin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000709	CcSEcCtD
Fluvastatin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000139	0.000708	CcSEcCtD
Fluvastatin—Vomiting—Azathioprine—systemic scleroderma	0.000139	0.000706	CcSEcCtD
Fluvastatin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000138	0.000704	CcSEcCtD
Fluvastatin—Infestation NOS—Methotrexate—systemic scleroderma	0.000138	0.000701	CcSEcCtD
Fluvastatin—Infestation—Methotrexate—systemic scleroderma	0.000138	0.000701	CcSEcCtD
Fluvastatin—Rash—Azathioprine—systemic scleroderma	0.000137	0.0007	CcSEcCtD
Fluvastatin—Dermatitis—Azathioprine—systemic scleroderma	0.000137	0.000699	CcSEcCtD
Fluvastatin—Flushing—Prednisone—systemic scleroderma	0.000137	0.000699	CcSEcCtD
Fluvastatin—Headache—Azathioprine—systemic scleroderma	0.000137	0.000696	CcSEcCtD
Fluvastatin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000137	0.000695	CcSEcCtD
Fluvastatin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000695	CcSEcCtD
Fluvastatin—Dizziness—Leflunomide—systemic scleroderma	0.000136	0.000693	CcSEcCtD
Fluvastatin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000135	0.000686	CcSEcCtD
Fluvastatin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000134	0.000684	CcSEcCtD
Fluvastatin—Angiopathy—Prednisone—systemic scleroderma	0.000134	0.000683	CcSEcCtD
Fluvastatin—Conjunctivitis—Methotrexate—systemic scleroderma	0.000134	0.000682	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000134	0.000682	CcSEcCtD
Fluvastatin—Immune system disorder—Prednisone—systemic scleroderma	0.000134	0.00068	CcSEcCtD
Fluvastatin—Pain—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000675	CcSEcCtD
Fluvastatin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000675	CcSEcCtD
Fluvastatin—Arrhythmia—Prednisone—systemic scleroderma	0.000132	0.000673	CcSEcCtD
Fluvastatin—Sweating—Methotrexate—systemic scleroderma	0.000132	0.000672	CcSEcCtD
Fluvastatin—Vomiting—Leflunomide—systemic scleroderma	0.000131	0.000667	CcSEcCtD
Fluvastatin—Alopecia—Prednisone—systemic scleroderma	0.000131	0.000666	CcSEcCtD
Fluvastatin—Hypersensitivity—Lisinopril—systemic scleroderma	0.00013	0.000664	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.00013	0.000663	CcSEcCtD
Fluvastatin—Dizziness—Mycophenolic acid—systemic scleroderma	0.00013	0.000662	CcSEcCtD
Fluvastatin—Rash—Leflunomide—systemic scleroderma	0.00013	0.000661	CcSEcCtD
Fluvastatin—Dermatitis—Leflunomide—systemic scleroderma	0.00013	0.000661	CcSEcCtD
Fluvastatin—Mental disorder—Prednisone—systemic scleroderma	0.00013	0.00066	CcSEcCtD
Fluvastatin—Nausea—Azathioprine—systemic scleroderma	0.00013	0.00066	CcSEcCtD
Fluvastatin—Headache—Leflunomide—systemic scleroderma	0.000129	0.000657	CcSEcCtD
Fluvastatin—Erythema—Prednisone—systemic scleroderma	0.000129	0.000656	CcSEcCtD
Fluvastatin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000128	0.000651	CcSEcCtD
Fluvastatin—Asthenia—Lisinopril—systemic scleroderma	0.000127	0.000646	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000127	0.000646	CcSEcCtD
Fluvastatin—Pruritus—Lisinopril—systemic scleroderma	0.000125	0.000637	CcSEcCtD
Fluvastatin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000125	0.000636	CcSEcCtD
Fluvastatin—Rash—Mycophenolic acid—systemic scleroderma	0.000124	0.000631	CcSEcCtD
Fluvastatin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000124	0.00063	CcSEcCtD
Fluvastatin—Hepatitis—Methotrexate—systemic scleroderma	0.000124	0.00063	CcSEcCtD
Fluvastatin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000627	CcSEcCtD
Fluvastatin—Headache—Mycophenolic acid—systemic scleroderma	0.000123	0.000627	CcSEcCtD
Fluvastatin—Pharyngitis—Methotrexate—systemic scleroderma	0.000123	0.000625	CcSEcCtD
Fluvastatin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000624	CcSEcCtD
Fluvastatin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000624	CcSEcCtD
Fluvastatin—Nausea—Leflunomide—systemic scleroderma	0.000122	0.000623	CcSEcCtD
Fluvastatin—Diarrhoea—Lisinopril—systemic scleroderma	0.000121	0.000617	CcSEcCtD
Fluvastatin—Ill-defined disorder—Prednisone—systemic scleroderma	0.000119	0.000608	CcSEcCtD
Fluvastatin—Visual impairment—Methotrexate—systemic scleroderma	0.000119	0.000607	CcSEcCtD
Fluvastatin—Angioedema—Prednisone—systemic scleroderma	0.000118	0.000599	CcSEcCtD
Fluvastatin—Dizziness—Lisinopril—systemic scleroderma	0.000117	0.000596	CcSEcCtD
Fluvastatin—Erythema multiforme—Methotrexate—systemic scleroderma	0.000117	0.000595	CcSEcCtD
Fluvastatin—Nausea—Mycophenolic acid—systemic scleroderma	0.000117	0.000594	CcSEcCtD
Fluvastatin—Malaise—Prednisone—systemic scleroderma	0.000116	0.000591	CcSEcCtD
Fluvastatin—Vertigo—Prednisone—systemic scleroderma	0.000116	0.000589	CcSEcCtD
Fluvastatin—Syncope—Prednisone—systemic scleroderma	0.000115	0.000588	CcSEcCtD
Fluvastatin—Cardiac disorder—Methotrexate—systemic scleroderma	0.000115	0.000584	CcSEcCtD
Fluvastatin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000114	0.000582	CcSEcCtD
Fluvastatin—Loss of consciousness—Prednisone—systemic scleroderma	0.000113	0.000576	CcSEcCtD
Fluvastatin—Vomiting—Lisinopril—systemic scleroderma	0.000112	0.000573	CcSEcCtD
Fluvastatin—Angiopathy—Methotrexate—systemic scleroderma	0.000112	0.000571	CcSEcCtD
Fluvastatin—Immune system disorder—Methotrexate—systemic scleroderma	0.000112	0.000569	CcSEcCtD
Fluvastatin—Rash—Lisinopril—systemic scleroderma	0.000112	0.000568	CcSEcCtD
Fluvastatin—Dermatitis—Lisinopril—systemic scleroderma	0.000111	0.000568	CcSEcCtD
Fluvastatin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000111	0.000566	CcSEcCtD
Fluvastatin—Hypertension—Prednisone—systemic scleroderma	0.000111	0.000566	CcSEcCtD
Fluvastatin—Chills—Methotrexate—systemic scleroderma	0.000111	0.000565	CcSEcCtD
Fluvastatin—Headache—Lisinopril—systemic scleroderma	0.000111	0.000564	CcSEcCtD
Fluvastatin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00011	0.000559	CcSEcCtD
Fluvastatin—Arthralgia—Prednisone—systemic scleroderma	0.00011	0.000558	CcSEcCtD
Fluvastatin—Myalgia—Prednisone—systemic scleroderma	0.00011	0.000558	CcSEcCtD
Fluvastatin—Anxiety—Prednisone—systemic scleroderma	0.000109	0.000556	CcSEcCtD
Fluvastatin—Alopecia—Methotrexate—systemic scleroderma	0.000109	0.000556	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000109	0.000554	CcSEcCtD
Fluvastatin—Discomfort—Prednisone—systemic scleroderma	0.000108	0.000552	CcSEcCtD
Fluvastatin—Mental disorder—Methotrexate—systemic scleroderma	0.000108	0.000552	CcSEcCtD
Fluvastatin—Erythema—Methotrexate—systemic scleroderma	0.000108	0.000548	CcSEcCtD
Fluvastatin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000106	0.00054	CcSEcCtD
Fluvastatin—Dysgeusia—Methotrexate—systemic scleroderma	0.000105	0.000537	CcSEcCtD
Fluvastatin—Nausea—Lisinopril—systemic scleroderma	0.000105	0.000535	CcSEcCtD
Fluvastatin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000105	0.000535	CcSEcCtD
Fluvastatin—Infection—Prednisone—systemic scleroderma	0.000104	0.000532	CcSEcCtD
Fluvastatin—Back pain—Methotrexate—systemic scleroderma	0.000104	0.00053	CcSEcCtD
Fluvastatin—Shock—Prednisone—systemic scleroderma	0.000103	0.000526	CcSEcCtD
Fluvastatin—Nervous system disorder—Prednisone—systemic scleroderma	0.000103	0.000525	CcSEcCtD
Fluvastatin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000522	CcSEcCtD
Fluvastatin—Skin disorder—Prednisone—systemic scleroderma	0.000102	0.00052	CcSEcCtD
Fluvastatin—Hyperhidrosis—Prednisone—systemic scleroderma	0.000102	0.000517	CcSEcCtD
Fluvastatin—Anorexia—Prednisone—systemic scleroderma	0.0001	0.00051	CcSEcCtD
Fluvastatin—Ill-defined disorder—Methotrexate—systemic scleroderma	9.98e-05	0.000508	CcSEcCtD
Fluvastatin—Vomiting—Mycophenolate mofetil—systemic scleroderma	9.86e-05	0.000502	CcSEcCtD
Fluvastatin—Rash—Mycophenolate mofetil—systemic scleroderma	9.77e-05	0.000498	CcSEcCtD
Fluvastatin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	9.77e-05	0.000497	CcSEcCtD
Fluvastatin—Headache—Mycophenolate mofetil—systemic scleroderma	9.71e-05	0.000495	CcSEcCtD
Fluvastatin—Malaise—Methotrexate—systemic scleroderma	9.7e-05	0.000494	CcSEcCtD
Fluvastatin—Vertigo—Methotrexate—systemic scleroderma	9.67e-05	0.000492	CcSEcCtD
Fluvastatin—Leukopenia—Methotrexate—systemic scleroderma	9.63e-05	0.000491	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	9.57e-05	0.000488	CcSEcCtD
Fluvastatin—Insomnia—Prednisone—systemic scleroderma	9.5e-05	0.000484	CcSEcCtD
Fluvastatin—Paraesthesia—Prednisone—systemic scleroderma	9.44e-05	0.000481	CcSEcCtD
Fluvastatin—Cough—Methotrexate—systemic scleroderma	9.39e-05	0.000478	CcSEcCtD
Fluvastatin—Dyspepsia—Prednisone—systemic scleroderma	9.25e-05	0.000471	CcSEcCtD
Fluvastatin—Nausea—Mycophenolate mofetil—systemic scleroderma	9.21e-05	0.000469	CcSEcCtD
Fluvastatin—Arthralgia—Methotrexate—systemic scleroderma	9.16e-05	0.000467	CcSEcCtD
Fluvastatin—Chest pain—Methotrexate—systemic scleroderma	9.16e-05	0.000467	CcSEcCtD
Fluvastatin—Myalgia—Methotrexate—systemic scleroderma	9.16e-05	0.000467	CcSEcCtD
Fluvastatin—Decreased appetite—Prednisone—systemic scleroderma	9.13e-05	0.000465	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	9.1e-05	0.000463	CcSEcCtD
Fluvastatin—Fatigue—Prednisone—systemic scleroderma	9.06e-05	0.000461	CcSEcCtD
Fluvastatin—Discomfort—Methotrexate—systemic scleroderma	9.05e-05	0.000461	CcSEcCtD
Fluvastatin—Constipation—Prednisone—systemic scleroderma	8.99e-05	0.000458	CcSEcCtD
Fluvastatin—Confusional state—Methotrexate—systemic scleroderma	8.86e-05	0.000451	CcSEcCtD
Fluvastatin—Anaphylactic shock—Methotrexate—systemic scleroderma	8.78e-05	0.000447	CcSEcCtD
Fluvastatin—Infection—Methotrexate—systemic scleroderma	8.72e-05	0.000444	CcSEcCtD
Fluvastatin—Feeling abnormal—Prednisone—systemic scleroderma	8.66e-05	0.000441	CcSEcCtD
Fluvastatin—Nervous system disorder—Methotrexate—systemic scleroderma	8.61e-05	0.000439	CcSEcCtD
Fluvastatin—Thrombocytopenia—Methotrexate—systemic scleroderma	8.6e-05	0.000438	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Prednisone—systemic scleroderma	8.59e-05	0.000438	CcSEcCtD
Fluvastatin—Skin disorder—Methotrexate—systemic scleroderma	8.53e-05	0.000434	CcSEcCtD
Fluvastatin—Hyperhidrosis—Methotrexate—systemic scleroderma	8.49e-05	0.000432	CcSEcCtD
Fluvastatin—Anorexia—Methotrexate—systemic scleroderma	8.37e-05	0.000426	CcSEcCtD
Fluvastatin—Urticaria—Prednisone—systemic scleroderma	8.35e-05	0.000425	CcSEcCtD
Fluvastatin—Abdominal pain—Prednisone—systemic scleroderma	8.31e-05	0.000423	CcSEcCtD
Fluvastatin—Body temperature increased—Prednisone—systemic scleroderma	8.31e-05	0.000423	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	8e-05	0.000407	CcSEcCtD
Fluvastatin—Insomnia—Methotrexate—systemic scleroderma	7.94e-05	0.000405	CcSEcCtD
Fluvastatin—Paraesthesia—Methotrexate—systemic scleroderma	7.89e-05	0.000402	CcSEcCtD
Fluvastatin—Dyspnoea—Methotrexate—systemic scleroderma	7.83e-05	0.000399	CcSEcCtD
Fluvastatin—Hypersensitivity—Prednisone—systemic scleroderma	7.74e-05	0.000394	CcSEcCtD
Fluvastatin—Dyspepsia—Methotrexate—systemic scleroderma	7.73e-05	0.000394	CcSEcCtD
Fluvastatin—Decreased appetite—Methotrexate—systemic scleroderma	7.63e-05	0.000389	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	7.58e-05	0.000386	CcSEcCtD
Fluvastatin—Fatigue—Methotrexate—systemic scleroderma	7.57e-05	0.000386	CcSEcCtD
Fluvastatin—Asthenia—Prednisone—systemic scleroderma	7.54e-05	0.000384	CcSEcCtD
Fluvastatin—Pain—Methotrexate—systemic scleroderma	7.51e-05	0.000382	CcSEcCtD
Fluvastatin—Pruritus—Prednisone—systemic scleroderma	7.43e-05	0.000379	CcSEcCtD
Fluvastatin—Feeling abnormal—Methotrexate—systemic scleroderma	7.24e-05	0.000369	CcSEcCtD
Fluvastatin—Diarrhoea—Prednisone—systemic scleroderma	7.19e-05	0.000366	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Methotrexate—systemic scleroderma	7.18e-05	0.000366	CcSEcCtD
Fluvastatin—Urticaria—Methotrexate—systemic scleroderma	6.98e-05	0.000355	CcSEcCtD
Fluvastatin—Dizziness—Prednisone—systemic scleroderma	6.95e-05	0.000354	CcSEcCtD
Fluvastatin—Abdominal pain—Methotrexate—systemic scleroderma	6.94e-05	0.000354	CcSEcCtD
Fluvastatin—Body temperature increased—Methotrexate—systemic scleroderma	6.94e-05	0.000354	CcSEcCtD
Fluvastatin—Vomiting—Prednisone—systemic scleroderma	6.68e-05	0.00034	CcSEcCtD
Fluvastatin—Rash—Prednisone—systemic scleroderma	6.63e-05	0.000337	CcSEcCtD
Fluvastatin—Dermatitis—Prednisone—systemic scleroderma	6.62e-05	0.000337	CcSEcCtD
Fluvastatin—Headache—Prednisone—systemic scleroderma	6.58e-05	0.000335	CcSEcCtD
Fluvastatin—Hypersensitivity—Methotrexate—systemic scleroderma	6.47e-05	0.00033	CcSEcCtD
Fluvastatin—Asthenia—Methotrexate—systemic scleroderma	6.3e-05	0.000321	CcSEcCtD
Fluvastatin—Nausea—Prednisone—systemic scleroderma	6.24e-05	0.000318	CcSEcCtD
Fluvastatin—Pruritus—Methotrexate—systemic scleroderma	6.21e-05	0.000316	CcSEcCtD
Fluvastatin—Diarrhoea—Methotrexate—systemic scleroderma	6.01e-05	0.000306	CcSEcCtD
Fluvastatin—Dizziness—Methotrexate—systemic scleroderma	5.81e-05	0.000296	CcSEcCtD
Fluvastatin—Vomiting—Methotrexate—systemic scleroderma	5.58e-05	0.000284	CcSEcCtD
Fluvastatin—Rash—Methotrexate—systemic scleroderma	5.54e-05	0.000282	CcSEcCtD
Fluvastatin—Dermatitis—Methotrexate—systemic scleroderma	5.53e-05	0.000282	CcSEcCtD
Fluvastatin—Headache—Methotrexate—systemic scleroderma	5.5e-05	0.00028	CcSEcCtD
Fluvastatin—Nausea—Methotrexate—systemic scleroderma	5.22e-05	0.000266	CcSEcCtD
